Nurix Therapeutics, Inc. financial data

Symbol
NRIX on Nasdaq
Industry
Pharmaceutical Preparations
Location
1700 Owens Street, Suite 205, San Francisco, CA
State of incorporation
DE
Fiscal year end
November 30
Former names
Nurix, Inc. (to 9/18/2015)
Latest financial report
10-K - Q4 2024 - Jan 28, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 507 % +26.8%
Debt-to-equity 39 % -9.21%
Return On Equity -53.7 % +9.79%
Return On Assets -38.6 % +7.21%
Operating Margin -195 % +55.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 75.9M shares +55.2%
Common Stock, Shares, Outstanding 75.9M shares +55.7%
Entity Public Float 996M USD +112%
Common Stock, Value, Issued 76K USD +55.1%
Weighted Average Number of Shares Outstanding, Basic 67.1M shares +23.5%
Weighted Average Number of Shares Outstanding, Diluted 67.1M shares +23.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 80.9M USD +94%
Revenue from Contract with Customer, Excluding Assessed Tax 12.6M USD -31.8%
Research and Development Expense 222M USD +17.2%
General and Administrative Expense 45.9M USD +7.09%
Operating Income (Loss) -213M USD -37.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -193M USD -34.3%
Income Tax Expense (Benefit) 270K USD
Net Income (Loss) Attributable to Parent -194M USD -34.5%
Earnings Per Share, Basic -2.88 USD/shares -8.68%
Earnings Per Share, Diluted -2.88 USD/shares -8.68%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 110M USD +101%
Marketable Securities, Current 217M USD -27.1%
Cash, Cash Equivalents, and Short-term Investments 610M USD +112%
Accounts Receivable, after Allowance for Credit Loss, Current 2M USD
Assets, Current 619M USD +110%
Property, Plant and Equipment, Net 17.8M USD +5.65%
Operating Lease, Right-of-Use Asset 28.1M USD -9.64%
Other Assets, Noncurrent 3.16M USD -17.4%
Assets 669M USD +88.2%
Accounts Payable, Current 11.5M USD +79.4%
Employee-related Liabilities, Current 16.6M USD +8.68%
Contract with Customer, Liability, Current 38.4M USD -20.2%
Liabilities, Current 95.9M USD +10.2%
Contract with Customer, Liability, Noncurrent 26.2M USD -41.8%
Operating Lease, Liability, Noncurrent 20.3M USD -12.3%
Liabilities 142M USD -8.22%
Accumulated Other Comprehensive Income (Loss), Net of Tax 150K USD
Retained Earnings (Accumulated Deficit) -739M USD -35.5%
Stockholders' Equity Attributable to Parent 527M USD +163%
Liabilities and Equity 669M USD +88.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -42M USD +13.4%
Net Cash Provided by (Used in) Financing Activities 1.62M USD +9.66%
Net Cash Provided by (Used in) Investing Activities 35.5M USD +121%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 75.9M shares +55.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -4.81M USD +84.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 99.9M USD +131%
Deferred Tax Assets, Valuation Allowance 227M USD +17.2%
Deferred Tax Assets, Gross 233M USD +15%
Operating Lease, Liability 28.3M USD -7.55%
Payments to Acquire Property, Plant, and Equipment 2.88M USD +26.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -193M USD -37.4%
Lessee, Operating Lease, Liability, to be Paid 38.5M USD -9.41%
Property, Plant and Equipment, Gross 52.3M USD +21.4%
Operating Lease, Liability, Current 8.01M USD +7.01%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.91M USD -36.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 8.24M USD +7.77%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 10.1M USD -14.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.99M USD +2.71%
Deferred Tax Assets, Operating Loss Carryforwards 91.8M USD -0.37%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 21.9M USD +41%
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.07M USD +2.71%
Operating Lease, Payments 1.92M USD +38.2%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 6.09M USD -31.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%